Over 300 Total Lots Up For Auction at Two Locations - UT 10/25, CA 10/28

IBA and RaySearch announce adaptive proton therapy strategic alliance

Press releases may be edited for formatting or style | September 06, 2016 Rad Oncology
Louvain-la-Neuve, Belgium, and Stockholm, Sweden, September 5, 2016 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer and RaySearch Laboratories, the global leader in treatment planning software, have entered into a long-term strategic alliance to combine their respective technologies and advance adaptive proton therapy.

As part of the collaboration, the RayCare® oncology information system, which is currently in development at RaySearch, will be customized for optimal use together with the IBA delivery solutions. In both RayStation and RayCare, as well as in the IBA delivery solutions, joint features, dedicated software interfaces and modified graphical user interface components will allow for a close and seamless workflow integration with optimized performances. The result will be a complete turnkey solution for all software and hardware needed to deliver outstanding adaptive proton therapy treatment.

Proton therapy is one of the most precise forms of radiation therapy: targets can be pinpointed with the optimal radiation dose, while adjacent tissue is spared to a much higher degree than with conventional radiation therapy. The technique is growing in popularity worldwide and studies are converging to point towards the fact that approximately 20% of radiation therapy patients could benefit from proton therapy while only 1% receive it today.

Johan Löf, Chief Executive Officer of RaySearch Laboratories, says: “IBA and RaySearch are committed to taking proton therapy to new levels. Through this collaboration with the world leader in proton therapy, we are giving clinics a complete platform that will optimize workflows and enable more precise and personalized treatment for patients. This will make it possible to realize the full potential of proton therapy.”

Olivier Legrain, Chief Executive Officer of IBA, said: “We are certain that proton therapy will improve care for an increasing percentage of cancer patients in the coming years. By combining IBA systems with RayCare and RayStation, we are creating what we see as the most comprehensive and innovative proton therapy solution available. This alliance is an important step toward adaptive proton therapy treatment that will broaden the spectrum of clinical application and enable the best possible result for cancer patients worldwide.”

About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

You Must Be Logged In To Post A Comment